# Procalcitonin and Endotoxin Sequential Levels to Optimize the Treatment of Bloodstream Infections

> **NCT00870623** · — · COMPLETED · sponsor: **University of Nebraska** · enrollment: 223 (actual)

## Conditions studied

- Bloodstream Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00870623
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06-01
- **Primary completion:** 2016-01-13
- **Final completion:** 2016-01-13
- **Target enrollment:** 223 (ACTUAL)
- **Last updated:** 2023-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00870623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00870623, "Procalcitonin and Endotoxin Sequential Levels to Optimize the Treatment of Bloodstream Infections". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00870623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*